Hydrea is an antineoplastic agent available for oral use as capsules. It is used to treat melanoma and chronic myelocytic leukemia. It is also used to treat recurrent, metastatic and inoperable carcinoma of the ovary. Hydrea is used with radiation therapy to control primary squamous cell carcinomas of the head and neck. Hydrea’s generic name is Hydroxyurea.